Philip Karlsson

PhD student at Department of Medical Biochemistry and Microbiology; Infection and Immunity; Helen Wang

E-mail:: philip.karlsson@imbim.uu.se
Visiting address:: BMC
Husargatan 3
752 37 UPPSALA
Postal address:: Box 582
751 23 UPPSALA

Download contact information for Philip Karlsson at Department of Medical Biochemistry and Microbiology; Infection and Immunity; Helen Wang

ORCID:: 0000-0003-0060-005X

Short presentation

Doctoral candidate at Uppsala University and currently serve as the Doctoral Board Representative in the University Board (Konsistoriet). I have previously worked at Uppsala University Hospital and been a visiting doctoral researcher at the University of Western Australia.

Keywords

Biography

BMSc in Biomedicine and MMsc in Infection Biology

Research

I investigate how bacteria interact within the urinary tract and how these interactions give rise to hard-to-treat infections in critically ill patients, with a particular focus on catheter-associated biofilms and the limitations of antibiotics in that environment. Previously, I worked on developing new microbiological diagnostic methods at Uppsala University Hospital and served as a visiting doctoral researcher at the Marshall Centre for Infectious Diseases Research in Australia.

Media

The use of broad-spectrum antibiotics increased drastically in intensive care at the beginning of the Covid-19 pandemic. At first, this helped patients avoid urinary tract infections and seemed to prevent the growth of most bacteria. However, it also contributed to a sharp growth in enterococci, an antibiotic-tolerant group of bacteria, which rendered the treatment of urinary tract infections more difficult.